Hearing Evaluation of Thalassemic Patients With Desferrioxamine Therapy in Qazvin Thalassemia Center and Tehran Pediatrics & Apos; Medical Center

Objective: The purpose of study was identify hearing loss in thalassemic patients with history of Desferrioxamine (DFO) therapy. This study was carried out in a cross-sectional descriptive survey on 195 thalassemic patients (3-30 years old) in Gazvin Thalassemia center and Tehran pediatrics&apos...

Full description

Bibliographic Details
Main Authors: Shoreh Jalaei, Dr. Ramezan Ali Sharifian, Dr. Ali Reza Karimi Yazdi, Sorayya Nili
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2003-08-01
Series:Audiology
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/6146.pdf&manuscript_id=6146